Welcome : Guest

Santen Pharmaceutical Co., Ltd. (Japan) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Santen Pharmaceutical Co., Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 24 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-02892
Price: $1200
Company Type: Public
Pages: 29
Date: February 2017
Market Data Tables: 24

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Santen Pharmaceutical Co., Ltd.'s Sales by Business Segment Worldwide (2014-2015) in Percentage for Pharmaceuticals Business (Prescription Pharmaceuticals (Ophthalmic, Anti-Rheumatics, Other Pharmaceuticals), and OTC Pharmaceuticals), and Other Business (Medical Devices)......5
Table 2: Santen Pharmaceutical Co., Ltd.'s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Japan, U.S., Europe, and Asia......6
Table 3: Santen Pharmaceutical Co., Ltd.'s Sales by Business Segment Worldwide (2014-2015) in Percentage for Pharmaceuticals (Prescription (Ophthalmic, Anti-rheumatics and Others), OTC (Over-The-Count)) and Other (Medical Devices and Others)......7
Table 4: Santen Pharmaceutical Co., Ltd.'s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Japan, Europe, North America, and Asia......8
Table 5: Santen Pharmaceutical Co., Ltd.’s Sales by Business Segment Worldwide (2014) in Percentage for Pharmaceuticals and Others......9
Ophthalmic Drugs......10
Table 6: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......10
Table 7: Ophthalmology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cataract & Vitreoretinal Surgery, Ophthalmic Lasers, and Vision Care......11
Table 8: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......12
Glaucoma Drugs......13
Table 9: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......13
Table 10: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......14
Table 11: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......15
Table 12: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......16
Table 13: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......17
Table 14: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......18
Cataract Market......19
Table 15: Cataract Surgeries Market in China (2015-2020) in RMB Million......19
Table 16: Visual Impairment Market by Category in Germany (2015) - Percentage Market Share Breakdown by Value for Cataract, Glaucoma, Uncorr Refrerrors, and Others......20
Table 17: Blindness Market by Category in Germany (2015) - Percentage Market Share Breakdown by Value for Age-Related Macular Degeneration, Cataract, Glaucoma, and Others......21
Intraocular Lens......22
Table 18: Vision Care Devices Market by Product Category Worldwide (2015) - Percentage Share Breakdown by Value for Contacts, Glasses, Intraocular Lens, and Others......22
Table 19: Intraocular Lens Market Worldwide (2015-2020) in US$ Million......23
Wet Age-Related Macular Degeneration (AMD) Anti Vascular Endothelial Growth Factor (VEGF)......24
Table 20: Wet Age-Related Macular Degeneration (AMD) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Avastin, Eylea, and Lucentis......24
Eyewear......25
Table 21: Eyewear Market by Product in the US (2015) - Percentage Share Breakdown by Value for Prescription Glasses (Single vision lenses for Hyperopia, Myopia or astigmatism Multifocal lenses (bifocal, Trifocal, Progressive lenses) also corrects Presbyopia), Sunglasses (UVA protection - c17% sunglasses volume in Europe with prescription), Contact Lenses and Others......25
Eylea......26
Table 22: Number of Patients for AVA-101 Therapy Drugs in the US (2015) – Percentage Market Share Breakdown by Volume for Avastin, Eylea, and Lucentis......26
Ophthalmology Drugs......27
Table 23: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......27
Table 24: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......28